Brands Convert Pilot Programs Into Commercial Contracts
Major consumer brands increasingly convert mycelium packaging pilot programs into standing commercial supply contracts, a shift driven by accumulating structural performance data spreading across a growing list of protective packaging categories each year across most major global markets. This addresses a genuine validation gap, since pilot-stage procurement previously left developers unable to secure the volume commitments needed to justify cultivation capacity expansion at meaningful commercial scale. Several developers have published structural performance validation data against drop-test standards, positioning documented reliability as the category's clearest differentiator heading into the next several years of expansion.
Market Impact: Adds 18% via ban coverage








